HGH Fragment 176-191
Growth Hormone & SecretagoguesA synthetic C-terminal fragment corresponding to residues 176-191 of the human growth hormone sequence. Used in lipid metabolism research models.
Synthetic fragment of the C-terminal region of human growth hormone, isolated for its lipolytic activity. Targets adipose tissue to promote fat breakdown and inhibit lipogenesis without influencing IGF-1, blood sugar, or growth-related pathways. Used in research focused on body composition and selective fat metabolism.
Also known asHGH Frag, Somatropin fragment 176-191, HGH Frag 176-191
Available formats
- Form
- Lyophilized powder
- Storage
- Store lyophilized at 2–8°C, protected from light. Ships at ambient temperature.
- CAS Number
- Available on request
- Molecular Formula
- Available on request
- Molecular Weight
- Available on request
- Purity
- Available on request
- Sequence
- Available on request
For laboratory research use only. Not for human or veterinary consumption. Not a drug, food, cosmetic, or medical device. Not for diagnostic or therapeutic use. Sold to qualified research and institutional buyers only.
Related products
Ipamorelin
A selective pentapeptide growth hormone secretagogue and ghrelin receptor agonist. Used as a reference standard in endocrine and receptor-binding research.
CJC-1295 No DAC
A tetra-substituted analogue of growth hormone releasing hormone (1-29) without the Drug Affinity Complex. Used in GHRH receptor research.
CJC-1295 DAC
A GHRH (1-29) analogue conjugated with a Drug Affinity Complex for extended plasma half-life. Used in peptide pharmacokinetics research.
Tesamorelin
A synthetic analogue of growth hormone releasing factor (1-44). Used as a reference compound in metabolic endocrinology research.